Scott Brun

Invests in

Biotech

Investments

Sources: the firm's website · curated public sources.

Colleagues at Abingworth

AA

Alex Asquith

Counsel at Abingworth

AK

Amit Khasgiwala

Investment Professional at Innovatus Capital Partners

AS

Andrew Sinclair

Managing Director, Head of Publics & Late Stage at Abingworth

AS

Ankur Shah

Vice President, CCD at Abingworth

AS

Anna Slezak

Senior Associate at Abingworth

BM

Bali Muralidhar

Global Head of Life Sciences & CIO at Abingworth

CP

Carlos Paya

Venture Partner at Ysios Capital

DL

David Leathers

General Partner at Abingworth

Frequently asked questions

Who is Scott Brun?

Scott Brun has over twenty years of experience in the pharmaceutical industry. He previously served as AbbVie's VP of Scientific Affairs and Head of AbbVie Ventures, where the ventures group grew to include more than 20 active companies, and earlier held roles as VP and Head of Pharmaceutical Development at AbbVie and drug development positions at Abbott Laboratories. He holds an MD from Johns Hopkins University School of Medicine and completed a residency in Ophthalmology at Harvard Medical School.

Where does Scott Brun work?

Scott Brun is Venture Partner at Abingworth.

What does Scott Brun invest in?

Scott Brun invests in Biotech.

What check size does Scott Brun write?

Scott Brun typically writes checks of $15M – $30M.

What boards does Scott Brun sit on?

Scott Brun holds tracked board seats at Axial Therapeutics, Horizon.

What companies has Scott Brun invested in?

Investments tracked here include Aquinnah Pharmaceuticals.

Where did Scott Brun go to school?

Scott Brun studied at Massachusetts Eye and Ear Infirmary, Harvard Medical School (Residency in Ophthalmology); The Johns Hopkins University School of Medicine (Doctor of Medicine); University of Illinois Urbana-Champaign (Bachelor of Science (B.S.), Biochemistry).